SBIR-STTR Award

Development of an Accessible, High-Precision Histology Procurement System
Award last edited on: 2/20/2019

Sponsored Program
SBIR
Awarding Agency
NIH : NIGMS
Total Award Amount
$148,360
Award Phase
1
Solicitation Topic Code
859
Principal Investigator
Michael Emmert-Buck

Company Information

Avoneaux Medical Institute LLC

6273 Waterloo Drive
Easton, MD 21601
   (443) 226-5578
   N/A
   N/A
Location: Single
Congr. District: 01
County: Talbot

Phase I

Contract Number: 1R43GM130189-01
Start Date: 8/1/2018    Completed: 1/30/2020
Phase I year
2018
Phase I Amount
$148,360
Tissues contain multiple cell types (nerve, vasculature, epithelium, fibroblasts) that enable their specialized physiological functions. Quantitative molecular analysis of cells from histological slides is useful in developing a deeper understanding of fundamental pathophysiology and in generating effective clinical interventions. Several strategies were developed in the past to more precisely recover cells from heterogeneous tissue sections, including manual razor scrapes, micromanipulators, and laser microdissection technologies. Laser dissection in particular has become an effective and established method, with several companies now offering high-level instrumentation and accompanying microgenomics assays. However, laser dissection instruments alone are not sufficient to fully meet the needs of the molecular pathology and biology fields. We recently invented a micropurification technology that can recover specific cells or subcellular structures from histology slides within minutes and with extreme precision. If successfully optimized and validated, the invention will expand the repertoire of tools available to the research, molecular pathology and oncology communities, and enable experiments requiring a level of precision that no current technology can accomplish. The two specific aims are: · Aim 1 ? Optimization of Cell and Nuclear Enrichment · Aim 2 ? Advancement of mRNA and miRNA Analyses

Project Terms:
Allelotyping; base; beta Actin; Biological Assay; Cell Nucleus; cell type; Cells; Cellular Structures; Clinic; Clinical; commercialization; Community Clinical Oncology Program; Cultured Cells; Data Analyses; Detection; Development; digital imaging; Dissection; DNA; DNA Mutational Analysis; Ensure; Epithelium; experimental study; Fibroblasts; Functional disorder; Future; Genes; Genomics; histological slides; Histology; improved; instrument; instrumentation; Intervention; invention; Laboratory Research; Lasers; Manuals; Measurement; Measures; Messenger RNA; Methods; Microdissection; microgenomics; micromanipulator; MicroRNAs; Mitochondrial DNA; Molecular Analysis; Molecular Biology; molecular oncology; molecular pathology; Mutation; Nerve; new technology; Nuclear; Physiological; Preparation; Process; process optimization; Quantitative Reverse Transcriptase PCR; Reproducibility; Research; research and development; Sampling; Slide; Subcellular structure; success; System; Technology; Temperature; Testing; Time; Tissues; tool; Transcript;

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----